chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Lip disorder, Lip erythema, Lip swelling, Paraesthesia oral
Clinical narrative: numbness and tingling in the tip of her tongue / bottom of her lip while eating food; tingling in the tip of her tongue / bottom of her lip while eating food; "bump" that was irritated and red on the top lip; other side of her lip started swelling / last day of the prednisone, overnight her lips "blew up"; red on the top lip.; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 10-May-2021 and was forwarded to Moderna on 10-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (numbness and tingling in the tip of her tongue / bottom of her lip while eating food), PARAESTHESIA ORAL (tingling in the tip of her tongue / bottom of her lip while eating food), LIP DISORDER ("bump" that was irritated and red on the top lip), LIP SWELLING (other side of her lip started swelling / last day of the prednisone, overnight her lips "blew up") and LIP ERYTHEMA (red on the top lip.) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced LIP DISORDER ("bump" that was irritated and red on the top lip), LIP SWELLING (other side of her lip started swelling / last day of the prednisone, overnight her lips "blew up") and LIP ERYTHEMA (red on the top lip.). On an unknown date, the patient experienced HYPOAESTHESIA ORAL (numbness and tingling in the tip of her tongue / bottom of her lip while eating food) and PARAESTHESIA ORAL (tingling in the tip of her tongue / bottom of her lip while eating food). At the time of the report, HYPOAESTHESIA ORAL (numbness and tingling in the tip of her tongue / bottom of her lip while eating food), PARAESTHESIA ORAL (tingling in the tip of her tongue / bottom of her lip while eating food), LIP DISORDER ("bump" that was irritated and red on the top lip), LIP SWELLING (other side of her lip started swelling / last day of the prednisone, overnight her lips "blew up") and LIP ERYTHEMA (red on the top lip.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Pain, Pain in extremity, Vaccination site pain
Clinical narrative: Could not sleep last night; Worse pain last night; Left arm injection site hurt more; Whole left arm sore, Whole left arm in excruciating pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Whole left arm sore, Whole left arm in excruciating pain), INSOMNIA (Could not sleep last night), PAIN (Worse pain last night) and VACCINATION SITE PAIN (Left arm injection site hurt more) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (Whole left arm sore, Whole left arm in excruciating pain). On 05-May-2021, the patient experienced VACCINATION SITE PAIN (Left arm injection site hurt more). On 09-May-2021, the patient experienced INSOMNIA (Could not sleep last night) and PAIN (Worse pain last night). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of UNK UNK, q4h. On 06-Mar-2021, PAIN IN EXTREMITY (Whole left arm sore, Whole left arm in excruciating pain) had resolved. On 10-May-2021, INSOMNIA (Could not sleep last night), PAIN (Worse pain last night) and VACCINATION SITE PAIN (Left arm injection site hurt more) had resolved.            No treatment medications were provided. No concomitant medications were provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-116483 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Follow-up information received and patient demographic was updated.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Product dose omission issue
Clinical narrative: tested positive for Covid-19 after getting the first shot; missed second dose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for Covid-19 after getting the first shot) and PRODUCT DOSE OMISSION ISSUE (missed second dose) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE (JANUMET) for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced COVID-19 (tested positive for Covid-19 after getting the first shot) and PRODUCT DOSE OMISSION ISSUE (missed second dose). At the time of the report, COVID-19 (tested positive for Covid-19 after getting the first shot) and PRODUCT DOSE OMISSION ISSUE (missed second dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Red Injection Site (2" Circumference); Itching Injection Site; Very Sore Injection Site; Swollen Injection Site; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 10-May-2021 and was forwarded to Moderna on 10-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching Injection Site), VACCINATION SITE ERYTHEMA (Red Injection Site (2" Circumference)), VACCINATION SITE PAIN (Very Sore Injection Site) and VACCINATION SITE SWELLING (Swollen Injection Site) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, the patient experienced VACCINATION SITE PAIN (Very Sore Injection Site) and VACCINATION SITE SWELLING (Swollen Injection Site). On 04-May-2021, the patient experienced VACCINATION SITE PRURITUS (Itching Injection Site). On 10-May-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red Injection Site (2" Circumference)). On 04-May-2021, VACCINATION SITE PAIN (Very Sore Injection Site) and VACCINATION SITE SWELLING (Swollen Injection Site) had resolved. At the time of the report, VACCINATION SITE PRURITUS (Itching Injection Site) and VACCINATION SITE ERYTHEMA (Red Injection Site (2" Circumference)) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No Relevant concomitant medications was reported. Treatment information was not provided.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Nasopharyngitis, Pyrexia, Vomiting
Clinical narrative: and a "bad cold"; "Throwing up"; "has had a low grade fever 99.2 degrees"; 2nd vaccine received at 38 days after 1st vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING ("Throwing up"), PYREXIA ("has had a low grade fever 99.2 degrees"), NASOPHARYNGITIS (and a "bad cold") and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd vaccine received at 38 days after 1st vaccine) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 027A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included OMEPRAZOLE, CARVEDILOL, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), Eletriptan, promethazine and Dihydroergotamine                                               for an unknown indication.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd vaccine received at 38 days after 1st vaccine). On 07-May-2021, the patient experienced VOMITING ("Throwing up"), PYREXIA ("has had a low grade fever 99.2 degrees") and NASOPHARYNGITIS (and a "bad cold"). On 07-May-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd vaccine received at 38 days after 1st vaccine) outcome was unknown. At the time of the report, VOMITING ("Throwing up"), PYREXIA ("has had a low grade fever 99.2 degrees") and NASOPHARYNGITIS (and a "bad cold") outcome was unknown.  Treatment information was provided i.e., Tylenol  The Action taken with mRNA-1273 in response to the events was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Malaise, Pain, Pain in extremity
Clinical narrative: Arm hurt; Achy; Tired; Not feeling well; This spontaneous case was reported by a patient and describes the occurrence of MALAISE (Not feeling well), PAIN IN EXTREMITY (Arm hurt), PAIN (Achy) and FATIGUE (Tired) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ROPINIROL [ROPINIROLE] and VERAPAMIL for an unknown indication.   On 28-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, the patient experienced MALAISE (Not feeling well), PAIN (Achy) and FATIGUE (Tired). On 28-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm hurt). At the time of the report, MALAISE (Not feeling well), PAIN IN EXTREMITY (Arm hurt), PAIN (Achy) and FATIGUE (Tired) outcome was unknown.            Treatment included ibuprofen
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Patient did not receive 2nd dose between day 25-35; This spontaneous case was reported by an other caregiver and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient did not receive 2nd dose between day 25-35) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04UA21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient did not receive 2nd dose between day 25-35). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient did not receive 2nd dose between day 25-35) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. The treatment information was unknown.   This case was linked to US-MODERNATX, INC.-MOD-2021-116456 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-116456:Wife case
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Hypoaesthesia, Migraine, Nausea
Clinical narrative: Nausea; My right side went numb from waist up; stroke-like symptoms; dizziness; felt like I was in a wave pool; migrane headaches;  the top of my head vibrating; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of DIZZINESS (dizziness; felt like I was in a wave pool), MIGRAINE (migrane headaches;  the top of my head vibrating), HYPOAESTHESIA (My right side went numb from waist up; stroke-like symptoms) and NAUSEA (Nausea) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029C20A and 039K20A) for COVID-19 vaccination.     No medical history provided by the reporter.  Concomitant products included VITAMIN B NOS (B-COMPLEX [VITAMIN B NOS]) for an unknown indication.   On 23-Dec-2020 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021 at 2:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced DIZZINESS (dizziness; felt like I was in a wave pool). 01-Mar-2021, the patient experienced MIGRAINE (migrane headaches;  the top of my head vibrating). On 19-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HYPOAESTHESIA (My right side went numb from waist up; stroke-like symptoms). On an unknown date, the patient experienced NAUSEA (Nausea). The patient was treated with MECLIZINE [MECLOZINE] for Dizziness, at a dose of 1 dosage form and PREDNISONE for Adverse event, at a dose of 1 dosage form. On 19-Apr-2021, HYPOAESTHESIA (My right side went numb from waist up; stroke-like symptoms) had resolved. On 01-May-2021, DIZZINESS (dizziness; felt like I was in a wave pool) and MIGRAINE (migrane headaches;  the top of my head vibrating) had resolved. At the time of the report, NAUSEA (Nausea) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Apr-2021, Computerised tomogram: normal (normal) normal- no indication of a stroke.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient reported trying meclizine and Sea bands for the dizziness, but neither therapy caused the dizziness to disappear. The migraine headaches were almost constant, not intense but always there to some degree. Both the dizziness and headache lasted about 8 weeks.  The stroke-like symptom only occurred once. The patient went to the ER and had a CT scan done. The patient was prescribed prednisone; the patient reported that the symptoms disappeared about 10-14 days after the steroid was initiated.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Additional events/event details provided, outcome  of all events updated to recovered/resolved (except dizziness) On 14-Jun-2021: Completed ADR Form updated patient's demographics and provided event and treatment details
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Sensitive skin
Clinical narrative: Sore arm; Sensitivity in her left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and SENSITIVE SKIN (Sensitivity in her left arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm) and SENSITIVE SKIN (Sensitivity in her left arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) and SENSITIVE SKIN (Sensitivity in her left arm) outcome was unknown. Not Provided          No concomitant medications provided.Treatment information was provided was steroids for 10 days.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045B21A and 030A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LORATADINE (CLARITINE) for Allergy.   On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Apr-2021, the patient experienced PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-May-2021, Body temperature: 100.2 (High) High.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitants included birth control.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Fatigue, Headache, Hyperhidrosis, Pyrexia
Clinical narrative: Chest pains that lasted on and off; Sweating; Tired; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pains that lasted on and off), HYPERHIDROSIS (Sweating), HEADACHE (Headache), FATIGUE (Tired) and PYREXIA (Fever) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, the patient experienced HEADACHE (Headache). On 08-May-2021, the patient experienced CHEST PAIN (Chest pains that lasted on and off), HYPERHIDROSIS (Sweating), FATIGUE (Tired) and PYREXIA (Fever). On 08-May-2021, CHEST PAIN (Chest pains that lasted on and off), HYPERHIDROSIS (Sweating) and PYREXIA (Fever) had resolved. On 09-May-2021, HEADACHE (Headache) and FATIGUE (Tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  No treatment details were provided.
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Dose [that] was drawn up on 05May2021, stored at 5C for 48 hours [was] then administered; Nurse used an expired syringe; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose [that] was drawn up on 05May2021, stored at 5C for 48 hours [was] then administered) and EXPIRED PRODUCT ADMINISTERED (Nurse used an expired syringe) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 07-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose [that] was drawn up on 05May2021, stored at 5C for 48 hours [was] then administered) and EXPIRED PRODUCT ADMINISTERED (Nurse used an expired syringe). On 07-May-2021, EXPIRED PRODUCT ADMINISTERED (Dose [that] was drawn up on 05May2021, stored at 5C for 48 hours [was] then administered) and EXPIRED PRODUCT ADMINISTERED (Nurse used an expired syringe) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.  No treatment information was provided.  Pharmacy kept 10 doses in the clinic refrigerator from which 8 doses were used. Nursing did not dispose the remaining syringes as instructed. 2 days later a nurse used one of the syringe and gave does to the patient.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Updated patient demographics(gender identified) , Added new event-nurse used expired syringe , updated outcome -recovered
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Tinnitus) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced TINNITUS (Tinnitus). At the time of the report, TINNITUS (Tinnitus) outcome was unknown. Not Provided          No concomitant medication were reported. No treatment information was reported.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia
Clinical narrative: Fever; body ache; Low grade Fever; headache; body aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Low grade Fever), HEADACHE (headache), MYALGIA (body aches), PYREXIA (Fever) and MYALGIA (body ache) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included COVID-19. Concomitant products included CLONAZEPAM for Anxiety, ATENOLOL for Blood pressure measurement.    On 05-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced PYREXIA (Low grade Fever), HEADACHE (headache) and MYALGIA (body aches). On 10-May-2021, the patient experienced PYREXIA (Fever) and MYALGIA (body ache). On 08-May-2021, PYREXIA (Low grade Fever), HEADACHE (headache) and MYALGIA (body aches) had resolved. At the time of the report, PYREXIA (Fever) and MYALGIA (body ache) outcome was unknown. Not Provided          Treatment included ibuprofen and Tylenol were noted.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Pain in extremity
Clinical narrative: Left leg hurts badly; Left leg hurts so badly that she couldn't walk or exercise.; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Left leg hurts badly) and GAIT DISTURBANCE (Left leg hurts so badly that she couldn't walk or exercise.) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Left leg hurts badly) and GAIT DISTURBANCE (Left leg hurts so badly that she couldn't walk or exercise.). At the time of the report, PAIN IN EXTREMITY (Left leg hurts badly) and GAIT DISTURBANCE (Left leg hurts so badly that she couldn't walk or exercise.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Treatment information was reported. No concomitant medication information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: Non significant F/UP: (Email obtained)
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itchiness on hand, head and feet; This spontaneous case was reported by an other health care professional and describes the occurrence of PRURITUS (Itchiness on hand, head and feet) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     Concomitant products included AMLODIPINE for Product used for unknown indication.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itchiness on hand, head and feet). The patient was treated with BUSPIRONE HYDROCHLORIDE (BUSPAR) at a dose of 15 mg twice a day; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and OMEPRAZOLE at an unspecified dose and frequency. At the time of the report, PRURITUS (Itchiness on hand, head and feet) outcome was unknown. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-116535 (Patient Link).
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Eye swelling, Hordeolum
Clinical narrative: Eye was swollen shut; Developed a sty on his eye; Right knee pain that was excruciating; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of EYE SWELLING (Eye was swollen shut), HORDEOLUM (Developed a sty on his eye) and ARTHRALGIA (Right knee pain that was excruciating) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     No Medical History was provided by the reporter.  Concomitant products included EZETIMIBE (ZETIA) and CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for an unknown indication.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced ARTHRALGIA (Right knee pain that was excruciating). On an unknown date, the patient experienced EYE SWELLING (Eye was swollen shut) and HORDEOLUM (Developed a sty on his eye). At the time of the report, EYE SWELLING (Eye was swollen shut) and HORDEOLUM (Developed a sty on his eye) outcome was unknown and ARTHRALGIA (Right knee pain that was excruciating) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medications taken were Unspecified pain killer combined with an anti-inflammatory, unspecified antibiotics.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Oropharyngeal discomfort, Pain, Pruritus
Clinical narrative: Throat is very scratchy; Headache; Diarrhea; Bright red rash from shoulder to elbow/rash on other arm in patches; Swollen with pain; Itchy, itching from back of shoulder to back; Swollen with pain; Very burning; Bright red rash from shoulder to elbow/rash on other arm in patches; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Bright red rash from shoulder to elbow/rash on other arm in patches), SWELLING (Swollen with pain), PRURITUS (Itchy, itching from back of shoulder to back), DIARRHOEA (Diarrhea) and OROPHARYNGEAL DISCOMFORT (Throat is very scratchy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: SHINGRIX. Concurrent medical conditions included Seasonal allergy since 10-May-2021.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced RASH ERYTHEMATOUS (Bright red rash from shoulder to elbow/rash on other arm in patches), SWELLING (Swollen with pain), PRURITUS (Itchy, itching from back of shoulder to back), PAIN (Swollen with pain), SKIN BURNING SENSATION (Very burning) and RASH (Bright red rash from shoulder to elbow/rash on other arm in patches). On 08-May-2021, the patient experienced DIARRHOEA (Diarrhea). On 09-May-2021, the patient experienced OROPHARYNGEAL DISCOMFORT (Throat is very scratchy) and HEADACHE (Headache). On 09-May-2021, DIARRHOEA (Diarrhea) and HEADACHE (Headache) had resolved. At the time of the report, RASH ERYTHEMATOUS (Bright red rash from shoulder to elbow/rash on other arm in patches), SWELLING (Swollen with pain), PRURITUS (Itchy, itching from back of shoulder to back), OROPHARYNGEAL DISCOMFORT (Throat is very scratchy), PAIN (Swollen with pain), SKIN BURNING SENSATION (Very burning) and RASH (Bright red rash from shoulder to elbow/rash on other arm in patches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant details were not provided. Treatment details include Cooling Cream.   This case was linked to MOD-2021-213523 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash erythematous, Skin burning sensation, Swelling
Clinical narrative: Throat is very scratchy; Headache; Diarrhea; Bright red rash from shoulder to elbow/rash on other arm in patches; Swollen with pain; Itchy, itching from back of shoulder to back; Swollen with pain; Very burning; Bright red rash from shoulder to elbow/rash on other arm in patches; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Bright red rash from shoulder to elbow/rash on other arm in patches), SWELLING (Swollen with pain), PRURITUS (Itchy, itching from back of shoulder to back), DIARRHOEA (Diarrhea) and OROPHARYNGEAL DISCOMFORT (Throat is very scratchy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: SHINGRIX. Concurrent medical conditions included Seasonal allergy since 10-May-2021.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced RASH ERYTHEMATOUS (Bright red rash from shoulder to elbow/rash on other arm in patches), SWELLING (Swollen with pain), PRURITUS (Itchy, itching from back of shoulder to back), PAIN (Swollen with pain), SKIN BURNING SENSATION (Very burning) and RASH (Bright red rash from shoulder to elbow/rash on other arm in patches). On 08-May-2021, the patient experienced DIARRHOEA (Diarrhea). On 09-May-2021, the patient experienced OROPHARYNGEAL DISCOMFORT (Throat is very scratchy) and HEADACHE (Headache). On 09-May-2021, DIARRHOEA (Diarrhea) and HEADACHE (Headache) had resolved. At the time of the report, RASH ERYTHEMATOUS (Bright red rash from shoulder to elbow/rash on other arm in patches), SWELLING (Swollen with pain), PRURITUS (Itchy, itching from back of shoulder to back), OROPHARYNGEAL DISCOMFORT (Throat is very scratchy), PAIN (Swollen with pain), SKIN BURNING SENSATION (Very burning) and RASH (Bright red rash from shoulder to elbow/rash on other arm in patches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant details were not provided. Treatment details include Cooling Cream.   This case was linked to MOD-2021-213523 (Patient Link).
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Dehydration, Feeding disorder, Feeling abnormal, Headache, Hyperhidrosis
Clinical narrative: Feeling bad; Sweating; Feels dehydrated; Not able to eat like before the vaccine; Nausea; Sore arm; Throwing up; Slight headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling bad), HYPERHIDROSIS (Sweating), DEHYDRATION (Feels dehydrated), FEEDING DISORDER (Not able to eat like before the vaccine) and NAUSEA (Nausea) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced FEELING ABNORMAL (Feeling bad), HYPERHIDROSIS (Sweating), DEHYDRATION (Feels dehydrated), FEEDING DISORDER (Not able to eat like before the vaccine), NAUSEA (Nausea), MYALGIA (Sore arm), VOMITING (Throwing up) and HEADACHE (Slight headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 08-May-2021, MYALGIA (Sore arm) had resolved. On 09-May-2021, NAUSEA (Nausea) and VOMITING (Throwing up) had resolved. At the time of the report, FEELING ABNORMAL (Feeling bad), HYPERHIDROSIS (Sweating), DEHYDRATION (Feels dehydrated), FEEDING DISORDER (Not able to eat like before the vaccine) and HEADACHE (Slight headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitants were not provided.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Vomiting
Clinical narrative: Feeling bad; Sweating; Feels dehydrated; Not able to eat like before the vaccine; Nausea; Sore arm; Throwing up; Slight headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling bad), HYPERHIDROSIS (Sweating), DEHYDRATION (Feels dehydrated), FEEDING DISORDER (Not able to eat like before the vaccine) and NAUSEA (Nausea) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced FEELING ABNORMAL (Feeling bad), HYPERHIDROSIS (Sweating), DEHYDRATION (Feels dehydrated), FEEDING DISORDER (Not able to eat like before the vaccine), NAUSEA (Nausea), MYALGIA (Sore arm), VOMITING (Throwing up) and HEADACHE (Slight headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 08-May-2021, MYALGIA (Sore arm) had resolved. On 09-May-2021, NAUSEA (Nausea) and VOMITING (Throwing up) had resolved. At the time of the report, FEELING ABNORMAL (Feeling bad), HYPERHIDROSIS (Sweating), DEHYDRATION (Feels dehydrated), FEEDING DISORDER (Not able to eat like before the vaccine) and HEADACHE (Slight headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitants were not provided.
Sex: U
Vaccine: COVID19
Symptoms: Dysgeusia, Hypoaesthesia
Clinical narrative: Metallic taste; Facial numbness; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Metallic taste) and HYPOAESTHESIA (Facial numbness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSGEUSIA (Metallic taste) and HYPOAESTHESIA (Facial numbness). At the time of the report, DYSGEUSIA (Metallic taste) and HYPOAESTHESIA (Facial numbness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitants and treatments were not provided.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Illness, Orthostatic hypotension, Palpitations
Clinical narrative: sick; drop in blood pressure when up standing; feels like her heart is racing; This spontaneous case was reported by an other caregiver and describes the occurrence of ORTHOSTATIC HYPOTENSION (drop in blood pressure when up standing), PALPITATIONS (feels like her heart is racing) and ILLNESS (sick) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included HYDROCHLOROTHIAZIDE and TRIAMTERENE for Blood pressure management.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced ORTHOSTATIC HYPOTENSION (drop in blood pressure when up standing) and PALPITATIONS (feels like her heart is racing). On an unknown date, the patient experienced ILLNESS (sick). At the time of the report, ORTHOSTATIC HYPOTENSION (drop in blood pressure when up standing), PALPITATIONS (feels like her heart is racing) and ILLNESS (sick) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, Blood pressure measurement: decreased (Low) decreased on standing.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.   This case was linked to MOD-2021-116517 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2021: Follow up received and contains information on second dose event details
Sex: F
Vaccine: COVID19
Symptoms: Back injury, Pruritus
Clinical narrative: While having a Bowel Movement she stain by injuring her lower back/ hip area on the right side; Itching on the scalp on the forehead; This spontaneous case was reported by a consumer and describes the occurrence of BACK INJURY (While having a Bowel Movement she stain by injuring her lower back/ hip area on the right side) and PRURITUS (Itching on the scalp on the forehead) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BACK INJURY (While having a Bowel Movement she stain by injuring her lower back/ hip area on the right side) and PRURITUS (Itching on the scalp on the forehead). At the time of the report, BACK INJURY (While having a Bowel Movement she stain by injuring her lower back/ hip area on the right side) and PRURITUS (Itching on the scalp on the forehead) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant Medication was provided. No treatment  was provided.  Patient also stated that canceled her 2nd shot and this week will be 5th week. Patient wanted to know if it was okay to take 2nd dose after 42 days.   Reporter did not allow further contact
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Mobility decreased, Myalgia, Night sweats
Clinical narrative: Night sweating; He couldn't do activities; Fever; Chills; Muscle pain; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of NIGHT SWEATS (Night sweating), MOBILITY DECREASED (He couldn't do activities), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Muscle pain) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C21A and 016B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Apr-2021, the patient experienced NIGHT SWEATS (Night sweating), MOBILITY DECREASED (He couldn't do activities), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Muscle pain) and FATIGUE (Fatigue). On 29-Apr-2021, NIGHT SWEATS (Night sweating), MOBILITY DECREASED (He couldn't do activities), PYREXIA (Fever) and CHILLS (Chills) had resolved. At the time of the report, MYALGIA (Muscle pain) and FATIGUE (Fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitants and treatments were not provided.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Night sweating; He couldn't do activities; Fever; Chills; Muscle pain; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of NIGHT SWEATS (Night sweating), MOBILITY DECREASED (He couldn't do activities), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Muscle pain) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C21A and 016B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Apr-2021, the patient experienced NIGHT SWEATS (Night sweating), MOBILITY DECREASED (He couldn't do activities), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Muscle pain) and FATIGUE (Fatigue). On 29-Apr-2021, NIGHT SWEATS (Night sweating), MOBILITY DECREASED (He couldn't do activities), PYREXIA (Fever) and CHILLS (Chills) had resolved. At the time of the report, MYALGIA (Muscle pain) and FATIGUE (Fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitants and treatments were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Asthenopia, Fatigue, Inflammation, Myalgia
Clinical narrative: panic attacks; inflammation above the throat, arm and groin; tired eyes like patient has not slept; pain in the legs/sore arm; felt weak; body aches; tired; This spontaneous case was reported by a consumer and describes the occurrence of PANIC ATTACK (panic attacks), INFLAMMATION (inflammation above the throat, arm and groin), ASTHENOPIA (tired eyes like patient has not slept), PAIN IN EXTREMITY (pain in the legs/sore arm) and ASTHENIA (felt weak) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PANIC ATTACK (panic attacks), INFLAMMATION (inflammation above the throat, arm and groin), ASTHENOPIA (tired eyes like patient has not slept), PAIN IN EXTREMITY (pain in the legs/sore arm), ASTHENIA (felt weak), MYALGIA (body aches) and FATIGUE (tired). At the time of the report, PANIC ATTACK (panic attacks), INFLAMMATION (inflammation above the throat, arm and groin), ASTHENOPIA (tired eyes like patient has not slept), PAIN IN EXTREMITY (pain in the legs/sore arm), ASTHENIA (felt weak), MYALGIA (body aches) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Panic attack
Clinical narrative: panic attacks; inflammation above the throat, arm and groin; tired eyes like patient has not slept; pain in the legs/sore arm; felt weak; body aches; tired; This spontaneous case was reported by a consumer and describes the occurrence of PANIC ATTACK (panic attacks), INFLAMMATION (inflammation above the throat, arm and groin), ASTHENOPIA (tired eyes like patient has not slept), PAIN IN EXTREMITY (pain in the legs/sore arm) and ASTHENIA (felt weak) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PANIC ATTACK (panic attacks), INFLAMMATION (inflammation above the throat, arm and groin), ASTHENOPIA (tired eyes like patient has not slept), PAIN IN EXTREMITY (pain in the legs/sore arm), ASTHENIA (felt weak), MYALGIA (body aches) and FATIGUE (tired). At the time of the report, PANIC ATTACK (panic attacks), INFLAMMATION (inflammation above the throat, arm and groin), ASTHENOPIA (tired eyes like patient has not slept), PAIN IN EXTREMITY (pain in the legs/sore arm), ASTHENIA (felt weak), MYALGIA (body aches) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia
Clinical narrative: Bodyaches; Chills; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Bodyaches) and CHILLS (Chills) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced MYALGIA (Bodyaches) and CHILLS (Chills). On 14-Feb-2021, MYALGIA (Bodyaches) and CHILLS (Chills) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication included.  No treatment medication included.   This case was linked to MOD-2021-046146 (Patient Link).
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: having pain in right shoulder; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (having pain in right shoulder) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048B21A and 032B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-May-2021, the patient experienced ARTHRALGIA (having pain in right shoulder). At the time of the report, ARTHRALGIA (having pain in right shoulder) outcome was unknown.            No concomitant medication were provided  Treatment medication was not provided